NPI: 1326001959 · DYERSBURG, TN 38024 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/06/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/06/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,066 | $368K |
| 2019 | 14,576 | $231K |
| 2020 | 6,819 | $142K |
| 2021 | 5,716 | $133K |
| 2022 | 3,046 | $110K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 20,480 | 1,643 | $968K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,795 | 887 | $15K |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,112 | 617 | $893.20 |
| J1756 | Injection, iron sucrose, 1 mg | 2,072 | 578 | $660.00 |
| 90674 | 15 | 15 | $25.94 | |
| G0008 | Administration of influenza virus vaccine | 47 | 47 | $3.38 |
| 83550 | 513 | 465 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 1,145 | 986 | $0.00 |
| 82728 | 542 | 492 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 58 | 54 | $0.00 |
| 82746 | 43 | 40 | $0.00 | |
| 83970 | 856 | 643 | $0.00 | |
| 85048 | 842 | 765 | $0.00 | |
| 85041 | 846 | 768 | $0.00 | |
| 83540 | 577 | 519 | $0.00 | |
| 85045 | 108 | 103 | $0.00 | |
| 82108 | 139 | 133 | $0.00 | |
| 90670 | 17 | 16 | $0.00 | |
| 90662 | 16 | 16 | $0.00 |